ARCHIVES

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Bill Reintroduced to Weaken U.S. Preventive Services Task Force

July 3, 2013

New Subcommittee Chairman Named

June 10, 1977

Eight States Get Cervical Cancer Screening Planning Contracts

June 21, 1974

In Brief: Mihich, Kennedy, Aust New Presidents; Loeb, Coltman, Cady Presidents Elect; Carbone Honored

May 29, 1987

Women Are Less Active After A Diagnosis of Breast Cancer

March 28, 2003

NCI director recognizes work of staff.

October 17, 2003